coronavirus vaccine by Moderna

Turkey negotiates the purchase of Moderna’s COVID-19 vaccine

Ankara negotiates with the US pharmaceutical company to buy its vaccine. Turkish citizens will be able to buy vaccines in pharmacies and hospitals.

Turkey negotiates the purchase of Moderna’s vaccine, which would join the vaccines of the Chinese pharmaceutical company Sinovac, the German-American Pfizer, and the recently acquired Russian vaccine Sputnik V, at a time when more than 21.8 million people have already been vaccinated in the country since vaccination began in January.

According to Turkish media, the Turkish authorities have already started negotiations with Moderna and they are progressing at a good pace; Ankara’s goal would be to expand and diversify its arsenal of coronavirus vaccines, and expand the stock to offer Turkish citizens a new option: the possibility of skipping the public waiting list to receive the COVID-19 vaccine, and acquire it by paying for it.

The Turkish government’s vaccination plan began in mid-January with the Sinovac vaccine, which was initially given to health workers and later also to the elderly. Currently, the majority of the 65-year-old population in the country has already been vaccinated, and a few days ago the vaccination process for citizens aged 55 and over began, prioritising teachers and people with jobs in key sectors.

This same week, Russia announced that a Turkish pharmaceutical company would produce the Sputnik V vaccine in the country; following the start of negotiations for the purchase of Moderna’s vaccine, Turkish companies have also entered into contacts with the US pharmaceutical company to mass-produce its vaccine in Turkey. Turkish authorities are also studying to sell doses of Moderna to pharmacies and hospitals so that they can be purchased individually by people.